Doctors News Hubb
Advertisement Banner
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
Doctors News Hubb
No Result
View All Result
Home News

miR-495-3p Enhances Sensitivity of BCR-ABL1-Expressing Leukemic Cells to TKIs by Targeting Multidrug Resistance One Gene in T315I-Mutated Cells

admin by admin
March 17, 2023
in News


The following is a summary of the “miR-495-3p sensitizes BCR-ABL1-expressing leukemic cells to tyrosine kinase inhibitors by targeting multidrug resistance 1 gene in T315I mutated cells,” published in the February 2023 issue of Experimental Hematology by Rittavee, et al.


Clonal haematological malignancy triggered by the BCR-ABL1 fusion oncoprotein defines chronic myeloid leukaemia (CML). Tyrosine kinase inhibitors (TKIs) have greatly improved patients’ chances of living a long time after their CML diagnosis. Nevertheless, amplification or mutations of the BCR-ABL1 oncogene and alterations in ATP-binding cassette (ABC) transporters account for about one-quarter of the patients who discontinue TKI treatment due to intolerance or resistance. There is mounting proof that the ATP-dependent efflux pump encoding gene MDR1 (multidrug resistance 1) is involved in miR-495-3p-mediated cancer chemoresistance. 

Their study intended to deduce the molecular circuitry underpinning miR-495-probable 3p’s role in CML TKI chemo-sensitivity. They first noticed a decrease in miR-495-3p expression in in vitro cellular models expressing BCR-ABL1. Increased proliferation, decreased numbers of nondividing cells (G0/G1), and resistance to Imatinib were all seen in loss-of-function tests. Their results, on the other hand, demonstrated that overexpression of miR-495-3p inhibited leukemic cell proliferation, TKI resistance in Imatinib-resistant T315I-mutant cells, and drug efflux activity via modulation of MDR1. 

Additional investigation into the involvement of miR-495-3p in CML patients revealed that expected miR-495-3p targets implicated in protein phosphorylation and linked with the worst prognosis were elevated in patients in blast crisis. Together, their findings highlight the importance of miR-495-3p downregulation in the malignant phenotype of CML and TKI resistance mechanisms, suggesting that miR-495-3p could serve as a biomarker and a therapeutic target in the fight to eradicate CML.

Source: sciencedirect.com/science/article/abs/pii/S0301472X22008384



Source link

Advertisement Banner
Previous Post

3 Pediatric Suction Scenarios You Will Likely Encounter

Next Post

THCB Gang Episode 120, Thursday March 16 – The Health Care Blog

Related Posts

News

QA AND Advocacy: How Pediatricians Can Improve LGBTQ Mental Healthcare

October 3, 2023
News

Simplified Assessment Tool Predicts Psoriasis Severity

October 2, 2023
News

Glucagon-like peptide-1 receptor agonists exhibit weight loss effects in non-diabetic patients with obesity

October 1, 2023
News

#VisualAbstract: Complete or Culprit-Only Percutaneous Coronary Intervention in Older Patients with Myocardial Infarction

September 30, 2023
News

Causal Impact of Circulating Proteome on Osteoarthritis Traits

September 29, 2023
News

Surprising Phacodonesis Risk in Pseudoexfoliation Patients During Cataract Surgery

September 28, 2023
Next Post

THCB Gang Episode 120, Thursday March 16 – The Health Care Blog

Recommended

Healthcare spending hit $4.3T in 2021 but growth slowed

10 months ago

Best Practices for Maintaining a Patient Airway in a Tough Situation

11 months ago

Calibrate Launches Enterprise Product to Bring GLP1 Weight Loss Drugs to Payers/Employers – The Health Care Blog

10 months ago

A Life Well Lived, Fights Well Fought – The Health Care Blog

5 months ago

Debt ceiling deal impacts health programs, but could’ve been worse

4 months ago

© Doctors News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

© 2022 Doctors News Hubb All rights reserved.